KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Endava (DAVA) Shares Outstanding (Diluted Average): 2017-2025

Historic Shares Outstanding (Diluted Average) for Endava (DAVA) over the last 9 years, with Sep 2025 value amounting to $71.8 million.

  • Endava's Shares Outstanding (Diluted Average) fell 7.07% to $71.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.8 million, marking a year-over-year decrease of 7.07%. This contributed to the annual value of $78.5 million for FY2025, which is 6.01% up from last year.
  • Per Endava's latest filing, its Shares Outstanding (Diluted Average) stood at $71.8 million for Q3 2025, which was down 8.63% from $78.5 million recorded in Q2 2025.
  • In the past 5 years, Endava's Shares Outstanding (Diluted Average) ranged from a high of $80.4 million in Q2 2021 and a low of $68.0 million during Q4 2022.
  • In the last 3 years, Endava's Shares Outstanding (Diluted Average) had a median value of $74.2 million in 2024 and averaged $74.3 million.
  • Per our database at Business Quant, Endava's Shares Outstanding (Diluted Average) climbed by 14.85% in 2021 and then declined by 14.01% in 2022.
  • Endava's Shares Outstanding (Diluted Average) (Quarterly) stood at $78.0 million in 2021, then decreased by 12.87% to $68.0 million in 2022, then rose by 6.56% to $72.4 million in 2023, then increased by 5.37% to $76.3 million in 2024, then declined by 7.07% to $71.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $71.8 million for Q3 2025, versus $78.5 million for Q2 2025 and $75.0 million for Q1 2025.